Cholesterol emboli syndrome is a multisystem disorder that can be precipitated by angiographic procedures. We report 5 cases in which the presentation was renal failure. All patients had undergone angiography, but the temporal relation of the procedure to the clinical presentation was highly variable, the interval ranging from one day to four months. With the increase in diagnostic and therapeutic uses of angiography, the cholesterol emboli syndrome is likely to become more frequent and needs to be recognized.
INTRODUCTION
Cholesterol emboli syndrome, also known as atheromatous embolization, was initially described by Panum in 1862 and later by Flory in the 1 940s. A multisystem disease caused by peripheral embolization of cholesterol crystals, it has been described as a complication of angiographic proceduresl6, following trauma, in association with anticoagulation and increasingly following thrombolysis7'8. It may also occur spontaneously in severe aortic atheromatous disease9.
The incidence is not known but in the past it was thought to have been a clinically uncommon entity. At necropsy Thurlbeck and reported on a series of 334 renal biopsies taken from patients over the age of 65 years who had undergone biopsy for acute, subacute and chronic renal failure, proteinuria and haematuria. 14 of these patients had histological evidence of cholesterol emboli, giving a prevalence in this selected population of 3.9%13. Another group'4 reviewed 14 998 arteriographic procedures conducted over nine years. 17 patients developed atheroembolic renal disease during this time, which equated to a final incidence of cholesterol embolization of 0.1 % per procedure. Here we report a series of 5 patients seen in a London renal unit.
CASE HISTORIES Case I
A 70-year-old male smoker was admitted with acute renal failure following acute myocardial infarction and associated left ventricular failure. He had a history of intermittent claudication, non-insulin-dependent diabetes mellitus and two previous myocardial infarctions. On examination renal bruits were audible. The creatinine was 251 pmol/L on admission. Renal artery stenosis was diagnosed clinically and confirmed by renal angiography. Angioplasty was not done at the time of the angiogram.
Within twenty-four hours of the procedure the patient complained of abdominal pain and on examination was tachycardic and hypertensive with a blood pressure of 190/ 1 10 mm Hg. Livedo reticularis had developed over the anterior abdominal wall and lower limbs. Renal function deteriorated and he required haemodialysis. Two days later he had a cerebral infarct and died.
Necropsy revealed severe generalized atherosclerosis with cerebral, myocardial, pulmonary and splenic infarcts. The kidneys were scarred and shrunken and there was severe bilateral renal artery stenosis. There was widespread histological evidence of cholesterol emboli involving the skin, the gut and the kidneys. Case 5 A man aged 75 was admitted because of worsening renal function. He had sustained three myocardial infarctions 12-15 years previously, was hypertensive and suffered from intermittent claudication. On admission his creatinine was 325 ,mol/L; edetate (EDTA) clearance was 12.6 mL/min. Arteriography revealed bilateral but functionally insignificant renal artery stenosis (20% on the left and 50% on the right). A subsequent attempt at renal angioplasty failed. Thereafter his creatinine rose to 950,mol/L within two weeks. Haemodialysis was started and the patient then sustained a myocardial infarct. He was subsequently maintained on continuous ambulatory peritoneal dialysis. His toes were noted to have become a dusky mottled blue, though peripheral arterial pressures were reasonable. An echocardiogram disclosed the presence of a mural thrombus and the patient was fully anticoagulated with warfarin. Thereafter, the patient became increasingly confused. CT brain scan revealed an old infarct only. Two months later acute liver failure developed and the patient died. Necropsy showed disseminated cholesterol emboli in the kidneys, spleen, liver, pancreas and adrenal glands.
DISCUSSION
Cholesterol crystal embolism results when atherosclerotic plaques become denuded of their endothelial lining and the substance of the plaque is exposed to the circulation. 100-200 lum in diameter, the crystals lodge in small vessels.
They then stimulate a local inflammatory response which deteriorated and he died two months after admission.
persists and leads to intravascular fibrosis, with distal ischaemia or infarction. The organs most commonly involved are the kidneys, skin, brain, heart, eye, muscle, gastrointestinal tract and the peripheries.
The syndrome has been described as the 'great masquerader', since the clinical manifestations mimic conditions ranging from systemic vasculitis to heparin toxicity3'15'16. They include blue toe syndrome (trash foot), livedo reticularis, gangrene, leg, foot or toe pain, abdominal, flank or back pain, haematuria, accelerated hypertension, deteriorating renal function and less commonly spinal cord, penile, splenic and adrenal infarction17. In one reported case, the first clinical expression of cholesterol emboli syndrome was peripheral neuropathy-presumably due to chronic ischaemia of the nerves18. Some patients describe fever, headache, myalgia and weight loss. The mortality rates are upwards of 70%, the usual case of death being cardiac, renal or multiorgan failurel9'20. Laboratory investigations tend to be nonspecific, with raised erythrocyte sedimentation rate, microcytic anaemia, leucocytosis (eosinophilia), and increased amylase and creatine kinase. Hypocomplementaemia has been reported by some investigators but not all20; this could arise by emboli activating complement directly by surface contact or indirectly through enzymes of the coagulation system. Eosinophilia may be related to activation of complement (C5a is chemotactic for eosinophils).
The kidney is the organ most commonly involved in cholesterol emboli syndrome, and renal failure often supervenes. Urinalysis may reveal proteinuria, haematuria, pyuria and urinary casts. Hypertension in this syndrome is believed to be related to activation of the renin-angiotensin system. It is often hard to control partly because it is episodic, when cholesterol emboli leave plaques in showers.
The presence of cholesterol emboli is confirmed by histology, usually from biopsies of skin, muscle or kidney22.
Biopsies of other sites may sometimes be helpful. In many cases the diagnosis is made post mortem.
No treatment is known to be effective. series all had factors that predispose to cholesterol emboli syndrome (Table 1) . Cholesterol emboli syndrome can present long after angiography, the interval ranging from one day to several months; often the angiography will have been done in a tertiary centre whereas the patient returns to the originating hospital. For these reasons diagnosis can be very difficult and the condition is probably under-reported. Increasingly in medicine angiographic procedures are used both diagnostically and therapeutically, so we can expect cholesterol emboli syndrome to become more frequent.
